Sort
48,018 grants matching “immunotherapy”
Rapid disease progression and viral reservoir formation in SIV-infected infant macaques
$938,584Donald L Sodora · Seattle Children'S Hospital · R01 · FY2021 · AI
High Throughput & Quantitative Cell Purification for ImmunotherapyManufacture
$938,534Coleman Murray · Ferrologix, Inc. · R44 · FY2021 · CA
The connection of innate and adaptive anti-cancer immunity
$937,885John Greiner · Division Of Basic Sciences - Nci · ZIA · FY2012 · CA
Molecular Pathogenesis of Neoplasia
$937,516Richard Youle · National Institute Of Neurological Disorders And Stroke · ZIA · FY2019 · NS
Stem Cell Biology, Cancer Stem Cell Biology, and Cancer Immunotherapy
$937,462Irving Lerner Weissman · Stanford University · R35 · FY2020 · CA
Development of novel immunotherapy for influenza virus infection
$937,230Kazue Takahashi · Massachusetts General Hospital · U01 · FY2010 · AI
Mechanisms of Immune-mediated Tumor Cell Destruction
$937,072Thomas J. Sayers · Basic Sciences · Z01 · FY2007 · CA
Clinical production of viral vectors for cancer gene therapy
$936,788Steven Feldman · Division Of Basic Sciences - Nci · ZIC · FY2013 · CA
Neonatal Porcine Islet Xenografts for the Treatment of Type 1 Diabetes
$936,759Allan D. Kirk · Duke University · U01 · FY2019 · AI
Mechanisms Of Immune Mediated Restriction Of HIV Replication In LTNP
$936,750Mark Connors · National Institute Of Allergy And Infectious Diseases · ZIA · FY2012 · AI
Immune function and the progression to type 1 diabetes
$936,569University Of Florida · P01 · FY2002 · AI
Immune Mechanisms, Genetic and Environmental Factors Influencing Outcomes
$936,517Scott H Sicherer · Icahn School Of Medicine At Mount Sinai · U19 · FY2012 · AI
Ann Arbor regional CCOP
$936,494Saint Joseph Mercy Health System · U10 · FY2002 · CA
Targeting the Epigenome for Lung Cancer Therapy
$936,250David Schrump · Division Of Clinical Sciences - Nci · Z01 · FY2008 · CA
Data-driven inference of regulators for cytokine-mediated tumor killing
$936,245Peng Jiang · Division Of Basic Sciences - Nci · ZIA · FY2024 · CA
Computational approaches for the analyses of spatial profiling technologies
$936,245Peng Jiang · Division Of Basic Sciences - Nci · ZIA · FY2024 · CA
Elucidation and targeting of paracrine cascades in PDAC
$936,242Kenneth P Olive · Columbia University Health Sciences · U01 · FY2024 · CA
Development of Ciclopirox Prodrug as a Novel Systemic Treatment for High-Risk Non-Muscle Invasive Bladder Cancer
$936,240William Mc Culloch · Ciclomed, Llc · R44 · FY2020 · CA
DEVELOPMENTAL FUNDS (Core 002)
$936,081Henry Shelton Earp · Univ Of North Carolina Chapel Hill · P30 · FY2019 · CA
Next Generation Cancer Immunotherapies to Defeat Melanoma
$936,000Antoni Ribas · University Of California Los Angeles · R35 · FY2022 · CA
Next Generation Cancer Immunotherapies to Defeat Melanoma
$936,000Antoni Ribas · University Of California Los Angeles · R35 · FY2025 · CA
Missouri Valley Cancer Consortium CCOP
$935,998Missouri Valley Cancer Consortium, Inc. · U10 · FY2005 · CA
Xenogeneic Stem Cell and Thymic Replacement in AIDS
$935,446Massachusetts General Hospital · P01 · FY2003 · AI
PATHWAYS TO TOLERANCE IN HUMAN ISLET TRANSPLANTATION
$935,038University Of Miami School Of Medicine · R01 · FY2000 · DK
Studying factors controlling cancer progression and immune recognition in mouse models
$934,920Tyler E Jacks · Massachusetts Institute Of Technology · R35 · FY2023 · CA